Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 26,336Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4NanoAlvand

02 1Granules India Limited

03 6Incyte Corporation

04 5Medichem S.A

05 8Novartis Pharmaceuticals Australia Pty Limited

06 14Novartis Pharmaceuticals Corporation

07 3Novartis South Africa (Pty) Ltd

08 3ORIFARM GROUP AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Regulatory Info :

Registration Country : India

Ruxolitinib Phosphate

Brand Name : Ruxolitinib Phosphate

Dosage Form : Immediate Release Tablet

Dosage Strength : 4.71%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Granules India

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

06

India Med Expo
Not Confirmed
arrow
arrow
India Med Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

07

India Med Expo
Not Confirmed
arrow
arrow
India Med Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

08

India Med Expo
Not Confirmed
arrow
arrow
India Med Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

09

India Med Expo
Not Confirmed
arrow
arrow
India Med Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

10

India Med Expo
Not Confirmed
arrow
arrow
India Med Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

11

India Med Expo
Not Confirmed
arrow
arrow
India Med Expo
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : OPZELURA

Dosage Form : CREAM;TOPICAL

Dosage Strength : EQ 1.5% BASE

Packaging :

Approval Date : 2021-09-21

Application Number : 215309

Regulatory Info : RX

Registration Country : USA

blank

12

India Med Expo
Not Confirmed
arrow

13

India Med Expo
Not Confirmed
arrow

14

India Med Expo
Not Confirmed
arrow

15

India Med Expo
Not Confirmed
arrow

16

India Med Expo
Not Confirmed
arrow

17

India Med Expo
Not Confirmed
arrow
arrow
India Med Expo
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

18

India Med Expo
Not Confirmed
arrow
arrow
India Med Expo
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 15 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

19

India Med Expo
Not Confirmed
arrow
arrow
India Med Expo
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 20 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

20

India Med Expo
Not Confirmed
arrow
arrow
India Med Expo
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 5 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank